Activation of the proto-oncogene TAL1 was linked to recurrent deletions of a nearby TAD boundary in T-ALL28, and we identify potential disruptions of this gene in esophagus cancer (translocation causing gain of eQTL and enhancer) and uterus cancer (translocation causing gain of eQTL). The gene discussed is TAL1; the disease is esophageal cancer.